These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 25517721)
1. More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutation. Hütter G N Engl J Med; 2014 Dec; 371(25):2437-8. PubMed ID: 25517721 [No Abstract] [Full Text] [Related]
2. More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutation. Verheyen J; Esser S; Kordelas L N Engl J Med; 2014 Dec; 371(25):2438. PubMed ID: 25517720 [No Abstract] [Full Text] [Related]
3. Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. Kordelas L; Verheyen J; Beelen DW; Horn PA; Heinold A; Kaiser R; Trenschel R; Schadendorf D; Dittmer U; Esser S; N Engl J Med; 2014 Aug; 371(9):880-2. PubMed ID: 25162903 [No Abstract] [Full Text] [Related]
4. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report. Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196 [TBL] [Abstract][Full Text] [Related]
5. HIV tropism shift: new paradigm on cell therapy strategies for HIV cure. Poveda E AIDS Rev; 2015; 17(1):65. PubMed ID: 25608470 [No Abstract] [Full Text] [Related]
6. Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells. Verheyen J; Thielen A; Lübke N; Dirks M; Widera M; Dittmer U; Kordelas L; Däumer M; de Jong DCM; Wensing AMJ; Kaiser R; Nijhuis M; Esser S Clin Infect Dis; 2019 Feb; 68(4):684-687. PubMed ID: 30020413 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of CCR5-Δ32 mutation in a cohort of Saudi stem cell donors. Alarifi M; Al-Amro F; Alalwan A; Al-Turki A; Fakhoury H; Atallah N; Al-Muallimi M; Al-Balwi M; Alzahrani M; Alaskar A; Hajeer A; Jawdat D HLA; 2017 Nov; 90(5):292-294. PubMed ID: 28731615 [TBL] [Abstract][Full Text] [Related]
8. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers. Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population. Takácová M; Nogová P; Hábeková M; Staneková D Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484 [TBL] [Abstract][Full Text] [Related]
10. [The first experience of application of standardized genotype technique of identification of HIV-tropism]. Lopatukhin AÉ; Kireev DE; Poliakov AN; Bukin EK; Kaiser R; Luebke N; Kuevda DA; Shipulin GA Klin Lab Diagn; 2013 Jun; (6):46-8. PubMed ID: 24340948 [TBL] [Abstract][Full Text] [Related]
11. Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis? Hedskog C; Mild M; Albert J J Infect Dis; 2012 Jan; 205(2):163-5. PubMed ID: 22147793 [No Abstract] [Full Text] [Related]
12. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Galvani AP; Novembre J Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976 [TBL] [Abstract][Full Text] [Related]
13. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy. Allers K; Schneider T Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158 [TBL] [Abstract][Full Text] [Related]
14. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review. Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889 [TBL] [Abstract][Full Text] [Related]
15. Reliable genotypic tropism tests for the major HIV-1 subtypes. Cashin K; Gray LR; Harvey KL; Perez-Bercoff D; Lee GQ; Sterjovski J; Roche M; Demarest JF; Drummond F; Harrigan PR; Churchill MJ; Gorry PR Sci Rep; 2015 Feb; 5():8543. PubMed ID: 25712827 [TBL] [Abstract][Full Text] [Related]
16. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. van Rij RP; Portegies P; Hallaby T; Lange JM; Visser J; de Roda Husman AM; van 't Wout AB; Schuitemaker H J Infect Dis; 1999 Sep; 180(3):854-7. PubMed ID: 10438379 [TBL] [Abstract][Full Text] [Related]
17. Genotypic tropism prediction from paired cell and plasma using single and replicate sequences. Coelho LP; Ferreira JL; Cabral GB; Guimarães PM; Brigido LF AIDS Res Hum Retroviruses; 2014 Jul; 30(7):711-6. PubMed ID: 24673579 [TBL] [Abstract][Full Text] [Related]
18. Relationship between CCR5 Martínez-Bonet M; González-Serna A; Clemente MI; Morón-López S; Díaz L; Navarro M; Puertas MC; Leal M; Ruiz-Mateos E; Martinez-Picado J; Muñoz-Fernández MA Clin Microbiol Infect; 2017 May; 23(5):318-324. PubMed ID: 28042001 [TBL] [Abstract][Full Text] [Related]
19. Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years. Soulie C; Lambert-Niclot S; Wirden M; Simon A; Valantin MA; Fourati S; Tubiana R; Katlama C; Calvez V; Marcelin AG AIDS; 2011 Feb; 25(4):537-9. PubMed ID: 21139487 [TBL] [Abstract][Full Text] [Related]
20. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort. Kalu AW; Telele NF; Gebreselasie S; Fekade D; Abdurahman S; Marrone G; Sönnerborg A BMC Infect Dis; 2017 Jan; 17(1):37. PubMed ID: 28061826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]